Novel Assay Using Total Hepatitis C Virus (HCV) Core Antigen quantification for Diagnosis of HCV Infection in Dialysis Patients

Dialysis patients remain a high-risk group for hepatitis C virus (HCV) infection. The current diagnosis of HCV infection among dialysis patients includes serological assays and nucleic acid amplification technology (NAT) for assessing serum anti-HCV antibody and HCV viremia, respectively. However, c...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Fabrizi, Fabrizio, Lunghi, Giovanna, Aucella, Filippo, Mangano, Stefano, Barbisoni, Francesco, Bisegna, Sergio, Vigilante, Domenico, Limido, Aurelio, Martin, Paul
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2005
Matèries:
Virology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC540167/
https://ncbi.nlm.nih.gov/pubmed/15635003
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.43.1.414-420.2005
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars